Search results

Tesla (TSLA) Q4 EPS Results

EPS vs. Wall St. Estimates: $0.50 actual, $0.45 expected (beat by 11%)

EPS: Down 32% year over year.

Revenue vs. Wall St. Estimates: Revenue of $24.901B actual, $24.78B

Fifth Third Bancorp FITB reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.08, surpassing the Zacks Consensus Estimate of $1.01. In the prior-year quarter, the company posted EPS

Comerica Incorporated CMA reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.46, beating the Zacks Consensus Estimate of $1.28. In the prior-year quarter, the company posted an EPS

Northern Trust Corporation’s NTRS fourth-quarter 2025 adjusted earnings per share (EPS) of $2.69 beat the Zacks Consensus Estimate of $2.37. In the prior-year quarter, the company reported an EPS of

General Motors GM is slated to release fourth-quarter 2025 results on Jan. 27, before market open. The Zacks Consensus Estimate for the to-be-reported quarter’s EPS and revenues is pegged at $2.19

Designed to provide broad exposure to the Style Box - Large Cap Value category of the market, the WisdomTree U.S. LargeCap ETF (EPS) is a smart beta exchange traded fund launched on 02/23/2007.

Cirrus Logic, Inc. CRUS reported third-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.97, which surpassed the Zacks Consensus Estimate of $2.42. The company reported adjusted EPS of

Cardinal Health, Inc. CAH reported second-quarter fiscal 2026 adjusted earnings per share (EPS) of $2.63, which beat the Zacks Consensus Estimate of $2.39 by 10%. The bottom line also improved 36.3%

PepsiCo, Inc.’s PEP productivity strategy is a key lever for earnings per share (EPS) expansion, particularly in a challenging operating environment. The company is driving productivity through a

Molina Healthcare, Inc. MOH reported a fourth-quarter 2025 adjusted loss of $2.75 per share, which missed the Zacks Consensus Estimate of an adjusted EPS of 43 cents. The company reported an EPS of

Biogen BIIB reported fourth-quarter 2025 adjusted earnings per share (EPS) of $1.99, which beat the Zacks Consensus Estimate of $1.61. Earnings declined 42% year over year.

Total revenues during the

Abbott Laboratories ABT is slated to report fourth-quarter 2025 results on Jan. 22, before the opening bell.

The company delivered adjusted earnings per share (EPS) of $1.30 in the last quarter

With inflationary pressures lingering across raw materials, logistics and labor, The Procter & Gamble Company PG is increasingly relying on productivity as a core earnings growth lever. Rather than

For the quarter ended December 2025, Mercantile Bank (MBWM) reported revenue of $62.07 million, up 6.1% over the same period last year. EPS came in at $1.40, compared to $1.22 in the year-ago

For the quarter ended December 2025, Comerica Incorporated (CMA) reported revenue of $850 million, up 0.7% over the same period last year. EPS came in at $1.46, compared to $1.20 in the year-ago

Fifth Third Bancorp (FITB) reported $2.34 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 7.9%. EPS of $1.12 for the same period compares to $0.90 a

For the quarter ended December 2025, Peoples Bancorp (PEBO) reported revenue of $117.32 million, up 5.1% over the same period last year. EPS came in at $0.93, compared to $0.82 in the year-ago

U.S. Bancorp (USB) reported $7.37 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 5.5%. EPS of $1.26 for the same period compares to $1.07 a year

KeyCorp (KEY) reported $2 billion in revenue for the quarter ended December 2025, representing a year-over-year increase of 13.3%. EPS of $0.41 for the same period compares to $0.38 a year ago.

The

For the quarter ended December 2025, Fastenal (FAST) reported revenue of $2.03 billion, up 11.1% over the same period last year. EPS came in at $0.26, compared to $0.23 in the year-ago quarter.

The